Boston Scientific Works Toward Restoring Operations Following Cybersecurity Incident
Boston Scientific reports no new unauthorized activity since Aug 25, while new cardiac device remote monitoring activations remain disrupted.
Boston Scientific reports no new unauthorized activity since Aug 25, while new cardiac device remote monitoring activations remain disrupted.
The company’s new positioning focuses on the integration of clinical engineering, cybersecurity, and data insights.
Masimo will operate as a stand-alone business within the Danaher diagnostics segment, focusing on patient monitoring and pulse oximetry.
Boston Scientific reports no new unauthorized activity since Aug 25, while new cardiac device remote monitoring activations remain disrupted.
The deal adds inspection, calibration, and repair services for outpatient and clinical settings as demand for reliable equipment support grows.
Read MoreThe medical technology company has agreed to be acquired by American Industrial Partners in an all-cash deal.
Read MoreThe program expansion includes two additional Da Vinci Xi models cleared by the Food and Drug Administration and the opening of new repair facilities in Texas and Arizona.
Read MoreTop 100 rankings to be announced in June.
Read MoreDeal expands enterprise imaging capabilities and adds cloud-based software across care settings.
Read MoreThe case centers on bundling and exclusive dealing practices in the surgical device market.
Read MoreThe longtime imaging executive joined Probo Medical in 2018 and previously led the company’s commercial operations.